These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


234 related items for PubMed ID: 11821987

  • 1. The effectiveness of tobramycin and Ocuflox in a prophylaxis model of Staphylococcus keratitis.
    Dajcs JJ, Moreau JM, Stroman DW, Schlech BA, Ke TL, Thibodeaux BA, Girgis DO, Caballero AR, O'Callaghan RJ.
    Curr Eye Res; 2001 Jul; 23(1):60-3. PubMed ID: 11821987
    [Abstract] [Full Text] [Related]

  • 2. Effectiveness of ciprofloxacin and ofloxacin in a prophylaxis model of Staphylococcus keratitis.
    Dajcs JJ, Moreau JM, Thibodeaux BA, Traidej M, Austin MS, Marquart ME, Stroman DW, O'Callaghan RJ.
    Cornea; 2001 Nov; 20(8):878-80. PubMed ID: 11685070
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A comparison of topical chlorhexidine, ciprofloxacin, and fortified tobramycin/cefazolin in rabbit models of Staphylococcus and Pseudomonas keratitis.
    Bu P, Riske PS, Zaya NE, Carey R, Bouchard CS.
    J Ocul Pharmacol Ther; 2007 Jun; 23(3):213-20. PubMed ID: 17593004
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Topical levofloxacin 1.5% overcomes in vitro resistance in rabbit keratitis models.
    Kowalski RP, Romanowski EG, Mah FS, Shanks RM, Gordon YJ.
    Acta Ophthalmol; 2010 Jun; 88(4):e120-5. PubMed ID: 20456251
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effect of topical povidone-iodine versus topical ofloxacin on experimental Staphylococcus keratitis.
    Melki SA, Safar A, Yaghouti F, Scharper P, Scharper M, Zeligs B, MacDowell AL, Goldberg MA, Lustbader J.
    Graefes Arch Clin Exp Ophthalmol; 2000 May; 238(5):459-62. PubMed ID: 10901479
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Topical ciprofloxacin versus topical fortified antibiotics in rabbit models of Staphylococcus and Pseudomonas keratitis.
    Lauffenburger MD, Cohen KL.
    Cornea; 1993 Nov; 12(6):517-21. PubMed ID: 8261784
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effectiveness of mupirocin and polymyxin B in experimental Staphylococcus aureus, Pseudomonas aeruginosa, and Serratia marcescens keratitis.
    Moreau JM, Conerly LL, Hume EB, Dajcs JJ, Girgis DO, Cannon BM, Thibodeaux BA, Stroman DW, O'Callaghan RJ.
    Cornea; 2002 Nov; 21(8):807-11. PubMed ID: 12410042
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.